Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, no par value per share
-
Shares outstanding
-
112,245,592
-
Total 13F shares
-
77,530,211
-
Share change
-
-124,038
-
Total reported value
-
$9,007,824,387
-
Put/Call ratio
-
140%
-
Price per share
-
$116.17
-
Number of holders
-
301
-
Value change
-
-$79,435,404
-
Number of buys
-
135
-
Number of sells
-
189
Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q3 2021
As of 30 Sep 2021,
NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by
301 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,530,211 shares.
The largest 10 holders included
Capital World Investors, Capital International Investors, BAILLIE GIFFORD & CO, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, CREDIT SUISSE AG/, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
301
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.